FindTrial
Sign In

exogenous insulin and indulin function

How to judge the results of insulin release test after injecting exogenous insulin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014910
Enrollment
Unknown
Registered
2018-02-17
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

2:stopping insulin injection one time

Sponsors

First People’s Hospital of Yunnan Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) type 2 diabetes; 2) insulin therapy for more than one month; 3) FBG< 7.0mmol/L; 4) the desire to discontinue the treatment of insulin.

Exclusion criteria

Exclusion criteria: 1) type 1 diabetes; 2) gestational diabetes mellitus; 3) liver and kidney insufficiency; 4) Uncontrolled blood sugar. 5) people who must be treated with insulin

Design outcomes

Primary

MeasureTime frame
serum insulin and c-peptide;—

Countries

China

Contacts

Public ContactYikun Zhou
yikunzhou22@sina.com+86 18908710522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026